Top Page
RHI Magnesita NV
(LSE:RHIM)
RHI Magnesita NV (RHIM) vs. iShares MSCI United Kingdom ETF (EWC)
RHI Magnesita NV Business Overview & Revenue Model
RHI Magnesita NV Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 3.57B | 3.49B | 3.57B | 3.32B | 2.55B | 2.26B | Gross Profit |
| 859.30M | 848.00M | 857.40M | 763.40M | 583.50M | 550.10M | EBIT |
| 306.05M | 0.00 | 306.80M | 343.60M | 360.90M | 211.90M | EBITDA |
| 453.30M | 472.00M | 507.30M | 477.80M | 463.20M | 351.60M | Net Income Common Stockholders |
| 185.60M | 142.00M | 164.60M | 155.70M | 243.10M | 24.80M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 527.70M | 577.00M | 708.00M | 495.50M | 559.10M | 587.20M | Total Assets |
| 3.54B | 4.58B | 4.85B | 4.07B | 3.91B | 3.05B | Total Debt |
| 1.15B | 1.82B | 2.00B | 1.67B | 1.59B | 1.16B | Net Debt |
| 658.60M | 1.24B | 1.31B | 1.18B | 1.03B | 572.20M | Total Liabilities |
| 2.65B | 3.20B | 3.49B | 3.03B | 3.09B | 2.39B | Stockholders Equity |
| 800.50M | 1.20B | 1.20B | 1.00B | 785.90M | 646.10M |
| Cash Flow | Free Cash Flow | ||||
| 311.90M | 288.00M | 320.20M | 77.10M | -343.90M | 162.10M | Operating Cash Flow |
| 496.40M | 433.00M | 499.70M | 233.80M | -91.80M | 319.00M | Investing Cash Flow |
| -333.90M | -154.00M | -482.00M | -199.70M | -128.90M | -137.90M | Financing Cash Flow |
| -312.00M | -409.00M | 178.00M | -83.90M | 197.70M | -17.70M |
RHI Magnesita NV Technical Analysis
RHI Magnesita NV Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £598.48M | 12.10 | 14.06% | 5.70% | -1.26% | 6.56% | |
74 Outperform | £207.06M | 17.55 | 14.84% | 1.72% | -2.36% | 118.64% | |
71 Outperform | £1.00B | 52.84 | 2.74% | 4.04% | -5.66% | -76.42% | |
67 Neutral | £241.99M | ― | -6.40% | ― | -21.84% | 10.56% | |
66 Neutral | $4.50B | 12.28 | 5.32% | 248.52% | 4.13% | -12.36% | |
65 Neutral | £1.34B | 11.14 | 11.86% | 5.33% | -4.96% | -13.52% |
RHI Magnesita NV Corporate Events
RHI Magnesita N.V. announced that as of May 31, 2025, its issued share capital comprises 47,294,191 ordinary shares, with an additional 2,183,514 shares held in treasury. This update is significant for shareholders and those with notification obligations under the FCA’s Disclosure Guidance and Transparency Rules, as it affects the calculation of their interests in the company.
The most recent analyst rating on (GB:RHIM) stock is a Buy with a £4150.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita N.V. announced that a person discharging managerial responsibilities exercised share options over 6,017 ordinary shares, which were subsequently sold. The transaction was part of the company’s Long Term Incentive Plan, with shares transferred from the company’s treasury account. This move reflects the company’s adherence to its incentive plans and regulatory compliance, potentially impacting its stock liquidity and market perception.
The most recent analyst rating on (GB:RHIM) stock is a Buy with a £4150.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita announced the appointment of Jann Brown as a Non-Executive Director on its board, effective from May 22, 2025. This strategic move is expected to enhance the company’s governance and potentially strengthen its market position, reflecting its ongoing commitment to leadership and growth in the refractory industry.
The most recent analyst rating on (GB:RHIM) stock is a Buy with a £4150.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita announced that all voting resolutions proposed at its Annual General Meeting on May 7, 2025, were passed by the required majority. Key resolutions included the adoption of the annual accounts, declaration of a final dividend, re-election of directors, and re-appointment of the external auditor. These decisions reflect strong shareholder support and are expected to reinforce the company’s strategic direction and operational stability.
RHI Magnesita’s Q1 2025 trading update reveals increased downside risks due to weak performance expectations and global trade tensions. The company faced challenging trading conditions with lower sales volumes and reduced margins, prompting cost-saving measures and a price increase program to restore profitability. The closure of the Wetro plant in Germany and the acquisition of Resco in North America are key strategic moves. Despite a rise in net debt, the company expects improved performance in the second half of the year, although macroeconomic volatility poses risks to achieving its full-year guidance.
RHI Magnesita has announced its total voting rights as of April 30, 2025, with an issued share capital of 47,279,213 ordinary shares, excluding 2,198,492 shares held in treasury. This figure is crucial for shareholders and others with notification obligations to determine their interest in the company under the FCA’s Disclosure Guidance and Transparency Rules.
RHI Magnesita N.V. announced that its CEO, Stefan Borgas, exercised share options under the company’s Long Term Incentive Plan, acquiring 58,755 ordinary shares. To cover the tax liabilities from this transaction, shares were sold on the London Stock Exchange, concluding the necessary sales. This announcement aligns with regulatory requirements and reflects the company’s commitment to transparency in managerial transactions.
RHI Magnesita N.V. announced that its CEO, Stefan Borgas, exercised share options over 58,755 ordinary shares as part of the company’s Long Term Incentive Plan. The shares, acquired in March 2022, are to be retained until March 2027, except for those sold to cover tax liabilities. Recent transactions involved the sale of shares on the London Stock Exchange to fund these tax obligations, with sales occurring on April 1 and April 2, 2025. This disclosure aligns with EU Market Abuse Regulation requirements, reflecting the company’s commitment to transparency in its financial dealings.
RHI Magnesita N.V. announced that its CEO, Stefan Borgas, exercised share options under the company’s Long Term Incentive Plan, acquiring 58,755 ordinary shares. To cover tax liabilities from this transaction, a portion of the shares was sold on the London Stock Exchange. This move is in compliance with the EU Market Abuse Regulation, reflecting transparency in managerial financial activities.
RHI Magnesita N.V. announced its total voting rights as of March 31, 2025, with an issued share capital of 47,235,004 ordinary shares, excluding 2,242,701 shares held in treasury. This information is crucial for shareholders and stakeholders to determine their notification obligations under the FCA’s Disclosure Guidance and Transparency Rules.
RHI Magnesita N.V. announced that its CEO, Stefan Borgas, exercised share options over 58,755 ordinary shares under the company’s Long Term Incentive Plan. The shares, vested on March 17, 2025, are subject to retention and clawback provisions, with some being sold to cover tax liabilities. This transaction reflects the company’s adherence to regulatory requirements and its commitment to transparent executive compensation practices.
RHI Magnesita has reissued its 2025 Annual General Meeting notice to include a proposal for the election of Franz-Ferdinand Buerstedde as a Non-Independent Non-Executive Director, nominated by Rhône Capital. This update aligns with the company’s governance practices and is now available for stakeholders on the company’s website and the National Storage Mechanism. The reissue of the AGM notice reflects RHI Magnesita’s commitment to transparent corporate governance and may influence its strategic direction by incorporating new leadership perspectives.
RHI Magnesita N.V. has proposed Franz-Ferdinand Buerstedde as a Non-Independent Non-Executive Director at its 2025 Annual General Meeting. Buerstedde, a Managing Director at Rhône Capital, brings extensive experience in investments across various sectors and holds significant board experience. His nomination is backed by Rhône Capital, which holds approximately 24% of RHI Magnesita’s capital. This strategic move is expected to enhance the company’s board with Buerstedde’s expertise, potentially impacting its operations and market positioning positively.
RHI Magnesita N.V. has announced the details of its 2025 Annual General Meeting (AGM), which will be conducted as a hybrid meeting, allowing shareholders to participate electronically and reducing the environmental impact of travel. This approach continues the company’s successful virtual meeting strategy since 2020, facilitating direct communication with the Board while maintaining cost efficiency and sustainability.